LeMaitre to Participate in Upcoming Investor Conferences

By GlobeNewswire

BURLINGTON, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

Stifel 2026 Healthcare Conference
Thursday, November 12, 2026
New York, NY
Dorian LeBlanc, CFO, will present at 8:00 AM EST

Jefferies 2026 Global Healthcare Conference
Tuesday, November 17, 2026
London, UK
Dorian LeBlanc, CFO, will present at 10:30 AM GMT

Piper Sandler 38th Annual Healthcare Conference
Thursday, December 3, 2026
New York, NY
Dorian LeBlanc, CFO, will present at 8:30 AM EST

About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact:

Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com


Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk